Concepedia
Statistics
Publications
11
Citations
841
H-Index
Active since
2012
Affiliations
University of Tübingen(Current)
University of Hohenheim
Universität Ulm
University Hospital Regensburg
Evotec (Germany)
Alexander Berger is an author at University of Tübingen specializing in pharmacology, molecular oncology, and oncology.
Publications per year
2012–2023
Comparison of Different Response Time Outlier Exclusion Methods: A Simulation Study
Alexander Berger, Markus Kiefer · Frontiers in Psychology · 2021 · 280 citations · Full text
Computing, Biostatistics, Epidemiologic Methods +13
Resveratrol as a Pan-HDAC Inhibitor Alters the Acetylation Status of Jistone Proteins in Human-Derived Hepatoblastoma Cells
Sascha Venturelli, Alexander Berger, Alexander Böcker et al. · PLoS ONE · 2013 · 168 citations · Full text
Medicine, Oncology, Pharmacology +11
Kaempferol, a new nutrition-derived pan-inhibitor of human histone deacetylases
Alexander Berger, Sascha Venturelli, Mascha Kallnischkies et al. · The Journal of Nutritional Biochemistry · 2012 · 112 citations
Life Sciences, Biochemistry, Pharmacology +11
Differential Induction of Apoptosis and Senescence by the DNA Methyltransferase Inhibitors 5-Azacytidine and 5-Aza-2′-Deoxycytidine in Solid Tumor Cells
Sascha Venturelli, Alexander Berger, Timo Weiland et al. · Molecular Cancer Therapeutics · 2013 · 97 citations
Medicine, Oncology, Pharmacology +17
Correction: Resveratrol as a Pan-HDAC Inhibitor Alters the Acetylation Status of Jistone Proteins in Human-Derived Hepatoblastoma Cells
Sascha Venturelli, Alexander Berger, Alexander Böcker et al. · PLoS ONE · 2013 · 53 citations · Full text
Medicine, Oncology, Pharmacology +12
1–5 of 11